Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences
Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, announced its executive leadership participation in two upcoming healthcare investor conferences. CEO Mojdeh Poul and CFO Lea Knight will present at the Wells Fargo Healthcare Conference on September 3, 2025, at 12:45 p.m. ET, and the Morgan Stanley Healthcare Conference on September 10, 2025, at 8:30 a.m. ET.
Investors can access live webcasts of both presentations through Integra LifeSciences' investor relations website under the Events & Presentations section.
Integra LifeSciences (NASDAQ:IART), società leader mondiale nel settore delle tecnologie medicali, ha comunicato la partecipazione della propria direzione esecutiva a due prossimi convegni per investitori nel settore sanitario. La CEO Mojdeh Poul e la CFO Lea Knight interverranno al Wells Fargo Healthcare Conference il 3 settembre 2025 alle 12:45 p.m. ET e al Morgan Stanley Healthcare Conference il 10 settembre 2025 alle 8:30 a.m. ET.
Gli investitori potranno seguire entrambe le presentazioni in diretta streaming tramite la sezione Events & Presentations del sito web Investor Relations di Integra LifeSciences.
Integra LifeSciences (NASDAQ:IART), compañía líder mundial en tecnología médica, anunció la participación de su equipo ejecutivo en dos próximas conferencias para inversores del sector salud. La CEO Mojdeh Poul y la CFO Lea Knight presentarán en la Wells Fargo Healthcare Conference el 3 de septiembre de 2025 a las 12:45 p.m. ET y en la Morgan Stanley Healthcare Conference el 10 de septiembre de 2025 a las 8:30 a.m. ET.
Los inversores podrán acceder a las retransmisiones en directo de ambas presentaciones a través de la sección Events & Presentations del sitio web de Investor Relations de Integra LifeSciences.
Integra LifeSciences (NASDAQ:IART), 세계적인 의료기술 기업인 인테그라는 경영진이 두 차례의 예정된 헬스케어 투자자 콘퍼런스에 참석한다고 발표했습니다. CEO Mojdeh Poul과 CFO Lea Knight는 2025년 9월 3일 오후 12:45(동부시간)에 열리는 Wells Fargo Healthcare Conference와 2025년 9월 10일 오전 8:30(동부시간)에 열리는 Morgan Stanley Healthcare Conference에서 발표할 예정입니다.
투자자들은 Integra LifeSciences의 투자자 관계 사이트 내 Events & Presentations 섹션을 통해 두 발표의 생중계를 시청할 수 있습니다.
Integra LifeSciences (NASDAQ:IART), entreprise mondiale de premier plan en technologies médicales, a annoncé la participation de sa direction à deux conférences à venir pour investisseurs du secteur de la santé. La CEO Mojdeh Poul et la CFO Lea Knight interviendront lors de la Wells Fargo Healthcare Conference le 3 septembre 2025 à 12:45 p.m. ET et de la Morgan Stanley Healthcare Conference le 10 septembre 2025 à 8:30 a.m. ET.
Les investisseurs pourront suivre les deux présentations en direct via la rubrique Events & Presentations du site Investor Relations d'Integra LifeSciences.
Integra LifeSciences (NASDAQ:IART), ein weltweit führendes Medizintechnikunternehmen, hat die Teilnahme seiner Geschäftsleitung an zwei bevorstehenden Healthcare-Investorenkonferenzen angekündigt. CEO Mojdeh Poul und CFO Lea Knight werden beim Wells Fargo Healthcare Conference am 3. September 2025 um 12:45 p.m. ET sowie beim Morgan Stanley Healthcare Conference am 10. September 2025 um 8:30 a.m. ET auftreten.
Investoren können beide Präsentationen live über die Rubrik Events & Presentations auf der Investor-Relations-Webseite von Integra LifeSciences verfolgen.
- None.
- None.
PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at two upcoming investor healthcare conferences:
- Wells Fargo Healthcare Conference on September 3, 2025, at 12:45 p.m. ET
- Morgan Stanley Healthcare Conference on September 10, 2025, at 8:30 a.m. ET
A live webcast of the presentations will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
Integra LifeSciences Holdings Corporation
FAQ
When is Integra LifeSciences (IART) presenting at the Wells Fargo Healthcare Conference 2025?
When is Integra LifeSciences (IART) presenting at the Morgan Stanley Healthcare Conference 2025?
Who will represent Integra LifeSciences (IART) at the upcoming healthcare conferences?
How can investors access Integra LifeSciences' (IART) conference presentations?
